The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025

Thursday, December 20, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 19, 2018 /PRNewswire/ -- Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025

Read the full report: https://www.reportlinker.com/p05563953 Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain
management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025.Upsurge in geriatric population that is highly susceptible to pain and chronic disorders has a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques has propelled the demand for endoscopic RFA across healthcare settings, thus fueling the market growth.However, dearth of skilled professionals that lack complete know-how of endoscopic RFA treatment impedes the market growth. Conversely, high untapped potential in the emerging economies is anticipated to offer significant profitable opportunities for the expansion of the market.The endoscope + radiofrequency ablation (RFA) market is segmented based on application. On the basis of application, the market is categorized into cardiology applications, pain management, oncology applications, and others.KEY BENEFITSThis report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global endoscope + radiofrequency ablation (RFA) market.Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.A qualitative analysis based on innovative products and devices facilitate the strategic business planning.The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.KEY MARKET SEGMENTSBy ApplicationCardiology ApplicationsPain ManagementOncology ApplicationsOther ApplicationsKEY MARKET PLAYERSBoston Scientific CorporationConmed CorporationMedtronic Plc.Smith & Nephew Plc.Stryker CorporationRead the full report: https://www.reportlinker.com/p05563953 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-endoscope--radiofrequency-ablation-rfa-market-was-valued-at-3-567-4-million-in-2017-and-is-estimated-to-reach-at-7-471-5-million-by-2025--registering-a-cagr-of-9-6-from-2018-to-2025--300768888.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store